Shiga ToxinsTrihexosylceramidesShiga Toxin 1Shiga ToxinShiga Toxin 2Shigella dysenteriaeToxicity TestsBacterial ToxinsToxicity Tests, AcuteEscherichia coliDose-Response Relationship, DrugLethal Dose 50Antineoplastic Combined Chemotherapy ProtocolsToxicity Tests, ChronicDrug Administration ScheduleAntineoplastic AgentsTreatment OutcomeCisplatinInfusions, IntravenousNo-Observed-Adverse-Effect LevelFluorouracilCell SurvivalMaximum Tolerated DoseNeoplasmsAdministration, OralDoxorubicinCombined Modality TherapyTime FactorsToxicologyDeoxycytidineDrug EvaluationLeukopeniaAntineoplastic Agents, PhytogenicDrug-Related Side Effects and Adverse ReactionsAntimetabolites, AntineoplasticRadiation InjuriesPaclitaxelDrug-Induced Liver InjuryLiverNeutropeniaToxicity Tests, SubchronicAntidotesSurvival AnalysisCamptothecinCyclophosphamideDisease-Free SurvivalRadiotherapy DosageCarboplatinHematologic DiseasesLung NeoplasmsTaxoidsTeratogensDrug Evaluation, PreclinicalSurvival RateOrganoplatinum CompoundsWater Pollutants, ChemicalLeucovorinThrombocytopeniaEtoposideAnimal Testing AlternativesEnvironmental PollutantsGlutathioneRats, Sprague-DawleyInsecticidesVinblastineMethotrexateRadiotherapyAntineoplastic Agents, AlkylatingDrug InteractionsOrgan SizeCells, CulturedNauseaToxicity Tests, SubacuteNeurotoxicity SyndromesPlant ExtractsDose FractionationVincristineBody WeightAntibiotics, AntineoplasticNanoparticlesRadiotherapy, ConformalAntibodies, MonoclonalArea Under CurveCell Line, TumorOxidative StressNeoplasm StagingKidneyNeoplasm MetastasisAcetaminophenPlant PoisoningApoptosisTissue DistributionDrug SynergismRemission InductionCell LineNeoplasm Recurrence, LocalCell DeathInjections, IntravenousSalvage TherapyStomatitis